Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1326
1
Atara Biotherapeutics, Inc. Atara Biotherapeutics Reports $85.4M Net Loss and $128.9M Revenue for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1327
1
Encompass Health Corp Encompass Health Reports 29.5% Increase in Net Income to $455.7 Million for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1328
1
N-able, Inc. N-able Reports 10.5% Revenue Growth to $466.1 Million in Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1329
1
FINANCIAL INSTITUTIONS INC Financial Institutions, Inc. Reports $41.6 Million Net Loss for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1330
1
ACRES Commercial Realty Corp. ACRES Commercial Realty Reports $9.1 Million Net Income for 2024, Driven by Increased Interest Income

Via official filing (AI summary) | about 1 month ago | 0 comments

1331
1
CARGO Therapeutics, Inc. CARGO Therapeutics Reports $167.5 Million Net Loss for 2024, Discontinues FIRCE-1 Study

Via official filing (AI summary) | about 1 month ago | 0 comments

1332
1
GREAT SOUTHERN BANCORP, INC. Great Southern Bancorp Reports 2.9% Increase in Total Assets, Net Income Declines 8.8%

Via official filing (AI summary) | about 1 month ago | 0 comments

1333
1
Sterling Bancorp, Inc. Sterling Bancorp Reports $2.1 Million Net Income Decline, Enters Sale Agreement for Subsidiary

Via official filing (AI summary) | about 1 month ago | 0 comments

1334
1
Investar Holding Corp Investar Holding Corporation Reports $20.3 Million Net Income for 2024, 21.4% Increase Year-Over-Year

Via official filing (AI summary) | about 1 month ago | 0 comments

1335
1
Maiden Holdings, Ltd. Maiden Holdings Reports $201M Net Loss in 2024, Strategic Shift and Kestrel Transaction Announced

Via official filing (AI summary) | about 1 month ago | 0 comments

1336
1
Aligos Therapeutics, Inc. Aligos Therapeutics Reports $131.2 Million Net Loss for 2024, Revenue Declines

Via official filing (AI summary) | about 1 month ago | 0 comments

1337
1
CAMDEN NATIONAL CORP Camden National Corporation Reports 22% Increase in Net Income for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1338
1
OFS Capital Corp OFS Capital Reports Increase in NAV and Decline in Net Investment Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1339
1
Wave Life Sciences Ltd. Wave Life Sciences Reports $97M Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1340
1
Prelude Therapeutics Inc Prelude Therapeutics Reports $127.2 Million Net Loss for 2024, Highlights Clinical Trial Developments

Via official filing (AI summary) | about 1 month ago | 0 comments

1341
1
Main Street Capital CORP Main Street Capital Corporation Reports 8% Increase in Total Investment Income for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1342
1
Instil Bio, Inc. Instil Bio Reports $74.1 Million Net Loss for 2024, Highlights Key Developments in Clinical Trials

Via official filing (AI summary) | about 1 month ago | 0 comments

1343
1
Design Therapeutics, Inc. Design Therapeutics Reports $49.6 Million Net Loss for 2024, Decreased Operating Expenses

Via official filing (AI summary) | about 1 month ago | 0 comments

1344
1
Passage BIO, Inc. Passage Bio Reports $64.7 Million Net Loss for 2024, Highlights Operational Developments

Via official filing (AI summary) | about 1 month ago | 0 comments

1345
1
Carter Bankshares, Inc. Carter Bankshares Reports $24.5 Million Net Income for 2024, Shifts Focus to Growth Strategy

Via official filing (AI summary) | about 1 month ago | 0 comments

1346
1
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals Reports $301.7 Million Net Loss for 2024 Following Product Withdrawal

Via official filing (AI summary) | about 1 month ago | 0 comments

1347
1
WILSON BANK HOLDING CO Wilson Bank Holding Company Reports $56.53 Million Net Earnings for 2024, 15.51% Increase

Via official filing (AI summary) | about 1 month ago | 0 comments

1348
1
Emergent BioSolutions Inc. Emergent BioSolutions Reports $190.6 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1349
1
FLAGSTAR FINANCIAL, INC. Flagstar Financial Reports $1.1 Billion Net Loss for 2024, Significant Strategic Changes Implemented

Via official filing (AI summary) | about 1 month ago | 0 comments

1350
1
Jasper Therapeutics, Inc. Jasper Therapeutics Reports $71.3 Million Net Loss for 2024, Advances Briquilimab in Clinical Trials

Via official filing (AI summary) | about 1 month ago | 0 comments